2-mercaptoethylguanidine has been researched along with Leukemia in 1 studies
2-mercaptoethylguanidine: proposed as a radiation protective agent; minor descriptor (75-83); on-line & Index Medicus search GUANIDINES (75-83); RN given refers to parent cpd
Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| AMBRUS, JL | 1 |
| AMBRUS, CM | 1 |
| PICKREN, JW | 1 |
| FELTZ, E | 1 |
| BACK, N | 1 |
1 other study available for 2-mercaptoethylguanidine and Leukemia
| Article | Year |
|---|---|
SELECTIVE PROTECTION OF THE GASTROINTESTINAL TRACT AGAINST RADIATION INJURY BY PERFUSION WITH MEG (2-MERCAPTOETHYLGUANIDINE HYDROBROMIDE).
Topics: Animals; beta-Aminoethyl Isothiourea; Bone Marrow Transplantation; Gastrointestinal Tract; Guanidine | 1965 |